Authors:
DUNN FW
ROUX MH
FARHADIAN F
SABRI K
OSSART C
SAMUEL JL
RAPPAPORT L
HAMON G
Citation: Fw. Dunn et al., HR-720, A NOVEL ANGIOTENSIN RECEPTOR ANTAGONIST INHIBITS THE ANGIOTENSIN-II-INDUCED TROPHIC EFFECTS, FIBRONECTIN RELEASE AND FIBRONECTIN-EIIIA(-MUSCLE CELLS IN-VITRO() EXPRESSION IN RAT AORTIC VASCULAR SMOOTH), The Journal of pharmacology and experimental therapeutics, 280(1), 1997, pp. 447-453
Citation: G. Hamon et al., PROTECTIVE EFFECT OF NIRAVOLINE, A KAPPA-OPIOID AGONIST, ON ENDOTOXIN-INDUCED ACUTE GASTROINTESTINAL LESIONS IN THE RAT, British Journal of Pharmacology, 120, 1997, pp. 194-194
Citation: R. Moreau et al., RENAL AND HEMODYNAMIC-RESPONSES TO A NOVEL KAPPA-OPIOID RECEPTOR AGONIST, NIRAVOLINE (RU-51,599) IN RATS WITH CIRRHOSIS, Journal of gastroenterology and hepatology, 11(9), 1996, pp. 857-863
Authors:
LAURENT S
VANHOUTTE P
CAVERO I
CHABRIER PE
DUPUIS B
ELGHOZI JL
HAMON G
JANIAK P
JUILLET Y
KHER A
KOEN R
MADONNA O
MAFFRAND JP
PRUNEAU D
THUILLEZ C
Citation: S. Laurent et al., THE ARTERIAL-WALL - A NEW PHARMACOLOGICAL AND THERAPEUTIC TARGET, Fundamental and clinical pharmacology, 10(3), 1996, pp. 243-257
Authors:
NEW JP
CANAVAN JP
FLYVBJERG A
HAMON G
BILOUS RW
MARSHALL SM
Citation: Jp. New et al., RENAL ENLARGEMENT AND INSULIN-LIKE GROWTH-FACTOR-I ACCUMULATION IN THE WISTAR RAT MODEL OF EXPERIMENTAL DIABETES IS NOT PREVENTED BY ANGIOTENSIN-CONVERTING ENZYME-INHIBITION, Diabetologia, 39(2), 1996, pp. 166-171
Citation: G. Hamon et S. Jouquey, EFFECTS OF SUBCHRONIC ADMINISTRATION OF NIRAVOLINE, A NOVEL AQUARETICCOMPOUND, ON WATER AND ELECTROLYTE RENAL EXCRETION IN CIRRHOTIC RATS, British Journal of Pharmacology, 117, 1996, pp. 224-224
Authors:
LAURENT S
VANHOUTTE P
CAVERO I
CHABRIER PE
DUPUIS B
ELGHOZI JL
HAMON G
JANIAK P
JUILLET Y
KHER A
KOEN R
MADONNA O
MAFFRAND JP
PRUNEAU D
THUILLEZ C
MOURAD JJ
Citation: S. Laurent et al., ARTERIAL-WALL - A NEW PHARMACOLOGICAL AND THERAPEUTIC TARGET, Therapie, 50(4), 1995, pp. 387-398
Authors:
JOUQUEY S
MATHIEU MN
HAMON G
CHEVILLARD C
Citation: S. Jouquey et al., EFFECT OF CHRONIC TREATMENT WITH TRANDOLAPRIL OR ENALAPRIL ON BRAIN ACE ACTIVITY IN SPONTANEOUSLY HYPERTENSIVE RATS, Neuropharmacology, 34(12), 1995, pp. 1689-1692
Authors:
SASSYPRIGENT C
HEUDES D
JOUQUEY S
AUBERVAL D
BELAIR MF
MICHEL O
HAMON G
BARIETY J
BRUNEVL P
Citation: C. Sassyprigent et al., MORPHOMETRIC DETECTION OF INCIPIENT GLOMERULAR-LESIONS IN DIABETIC NEPHROPATHY IN RATS - PROTECTIVE EFFECTS OF ACE-INHIBITION, Laboratory investigation, 73(1), 1995, pp. 64-71
Authors:
DEPREZ P
GUILLAUME J
BECKER R
CORBIER A
DIDIERLAURENT S
FORTIN M
FRECHET D
HAMON G
HECKMANN B
HEITSCH H
KLEEMANN HW
VEVERT JP
VINCENT JC
WAGNER A
ZHANG JD
Citation: P. Deprez et al., SULFONYLUREAS AND SULFONYLCARBAMATES AS NEW NON-TETRAZOLE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - DISCOVERY OF A HIGHLY POTENT ORALLY-ACTIVE (IMIDAZOLYLBIPHENYLYL) SULFONYLUREA (HR-720), Journal of medicinal chemistry, 38(13), 1995, pp. 2357-2377
Authors:
CHEVALIER B
HEUDES D
HEYMES C
BASSET A
DAKHLI T
BANSARD Y
JOUQUEY S
HAMON G
BRUNEVAL P
SWYNGHEDAUW B
CARRE F
Citation: B. Chevalier et al., TRANDOLAPRIL DECREASES PREVALENCE OF VENTRICULAR ECTOPIC ACTIVITY IN MIDDLE-AGED SHR, Circulation, 92(7), 1995, pp. 1947-1953
Authors:
HAMON G
CLEMENCE F
FORTIN M
LEMARTRET O
JOUQUEY S
VINCENT JC
PETIT F
BICHET DG
Citation: G. Hamon et al., NIRAVOLINE HYDROCHLORIDE, A NOVEL SELECTIVE KAPPA-AGONIST WITH MARKEDAQUARETIC PROPERTIES BUT LOW-ANALGESIC POTENCY, British Journal of Pharmacology, 114, 1995, pp. 310-310
Authors:
HAMON G
FORTIN M
LEMARTRET O
JOUQUEY S
VINCENT JC
BICHET DG
Citation: G. Hamon et al., PHARMACOLOGICAL PROFILE OF NIRAVOLINE - A NEW AQUARETIC COMPOUND, Journal of the American Society of Nephrology, 5(3), 1994, pp. 272-272
Authors:
CHEVILLARD C
JOUQUEY S
BREE F
MATHIEU MN
STEPNIEWSKI JP
TILLEMENT JP
HAMON G
CORVOL P
Citation: C. Chevillard et al., COMPARED PROPERTIES OF TRANDOLAPRIL, ENALAPRIL, AND THEIR DIACID METABOLITES, Journal of cardiovascular pharmacology, 23, 1994, pp. 190000011-190000015
Citation: S. Jouquey et al., TRANDOLAPRIL DOSE-RESPONSE IN SPONTANEOUSLY HYPERTENSIVE RATS - EFFECTS ON ACE ACTIVITY, BLOOD-PRESSURE, AND CARDIAC-HYPERTROPHY, Journal of cardiovascular pharmacology, 23, 1994, pp. 190000016-190000018
Authors:
VIENET R
GROGNET JM
EZAN E
LECAQUE D
HAMON G
CORMAN B
Citation: R. Vienet et al., EFFECT OF CHRONIC CONVERTING-ENZYME INHIBITION ON KIDNEY-FUNCTION OF SENESCENT HYPERTENSIVE RATS, Journal of cardiovascular pharmacology, 23, 1994, pp. 190000019-190000025
Authors:
CORBIER A
LECAQUE D
SECCHI J
DEPOUEZ B
HAMON G
Citation: A. Corbier et al., EFFECTS OF 4 WEEKS OF TREATMENT WITH TRANDOLAPRIL ON RENAL-HYPERTENSION AND CARDIAC AND VASCULAR HYPERTROPHY IN THE RAT, Journal of cardiovascular pharmacology, 23, 1994, pp. 190000026-190000029
Authors:
SECCHI J
LECAQUE D
DUNN FW
JOUQUEY S
AUBERVAL UD
BENZONI F
SIRUGUE O
HAMON G
Citation: J. Secchi et al., EFFECTS OF SUBCHRONIC TREATMENT WITH TRANDOLAPRIL AND ENALAPRIL ON CARDIOVASCULAR MORPHOLOGIC ALTERATIONS IN THE AGED SPONTANEOUSLY HYPERTENSIVE RAT WITH HEART-FAILURE, Journal of cardiovascular pharmacology, 23, 1994, pp. 190000030-190000037
Authors:
ELAMRANI FC
CHEAW SL
CHEVALIER B
PAOLAGGI F
JOUQUEY S
HAMON G
SWYNGHEDAUW B
Citation: Fc. Elamrani et al., REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY BY CONVERTING-ENZYME INHIBITION IN 12-15-MONTH-OLD SPONTANEOUSLY HYPERTENSIVE RATS - EFFECTS ON CORONARY RESISTANCE AND VENTRICULAR COMPLIANCE IN NORMOXIA AND ANOXIA, Journal of cardiovascular pharmacology, 23(1), 1994, pp. 155-165
Authors:
HAMON G
MULLOY RH
CHEN G
CHOW R
BIRKENMAIER C
HORN JK
Citation: G. Hamon et al., TRANSFORMING GROWTH FACTOR-BETA(1) LOWERS THE CD14 CONTENT OF MONOCYTES, The Journal of surgical research, 57(5), 1994, pp. 574-578
Authors:
STUCKER O
PONS C
DUVERGER JP
HAMON G
WANG X
TROUVE R
Citation: O. Stucker et al., IMPAIRMENT OF ARTERIOLAR SENSITIVITY TO ILOPROST IN DIABETIC RATS - PARTIAL RESTORATION BY CHRONIC TREATMENT WITH TRANDOLAPRIL, British Journal of Pharmacology, 112, 1994, pp. 210000039-210000039